Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ESR1 | P03372 | 2/20 | 0.33 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.31 |
| ▸ | HTR2A | P28223 | 1/20 | 0.31 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.31 |
| ▸ | HRH1 | P35367 | 1/20 | 0.31 |
| ▸ | HTR2B | P41595 | 1/20 | 0.31 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.31 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.31 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3689005 | 0.90 | IDO1 (0.42) | — | |
| SCHEMBL31019832 | 0.88 | HRH3 (0.44) | — | |
| SCHEMBL2011093 | 0.88 | TSHR (0.42) | — | |
| SCHEMBL706086 | 0.87 | TAAR1 (0.44) | SLC6A2 | |
| SCHEMBL2011622 | 0.84 | NR1H2 (0.35) | — | |
| SCHEMBL12885589 | 0.84 | RAB9A (0.39) | — | |
| SCHEMBL702989 | 0.82 | ALDH1A1 (0.44) | CHRNA4 | |
| SCHEMBL3823271 | 0.81 | NR1H2 (0.42) | — | |
| SCHEMBL1465904 | 0.79 | BCHE (0.37) | SLC6A2 | |
| SCHEMBL2011758 | 0.78 | ALDH1A1 (0.32) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 31 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2750799-B1 | PROCESS FOR THE ALKOXYCARBONYLATION OF FUNCTIONALIZED ALKENES | DSM IP ASSETS BV (NL) | 2016-01-06 | — | — | EP | claimed |
| US-9056829-B2 | Process for the alkoxycarbonylation of functionalized alkenes | DSM IP ASSETS B.V. (NL) | 2015-06-16 | — | — | US | claimed |
| US-8853434-B2 | Process for the isomerisation of substituted alkenes | DSM IP ASSETS B.V. (NL) | 2014-10-07 | — | — | US | claimed |
| US-20140206898-A1 | PROCESS FOR THE ISOMERISATION OF SUBSTITUTED ALKENES | DSM IP ASSETS B.V. (NL) | 2014-07-24 | — | — | US | claimed |
| US-20140206893-A1 | PROCESS FOR THE ALKOXYCARBONYLATION OF FUNCTIONALIZED ALKENES | DSM IP ASSETS B.V. (NL) | 2014-07-24 | — | — | US | claimed |
| EP-2750799-A1 | PROCESS FOR THE ALKOXYCARBONYLATION OF FUNCTIONALIZED ALKENES | DSM IP Assets B.V. (NL) | 2014-07-09 | — | — | EP | claimed |
| EP-2734498-A1 | PROCESS FOR THE ISOMERISATION OF SUBSTITUTED ALKENES | DSM IP Assets B.V. (NL) | 2014-05-28 | — | — | EP | claimed |
| WO-2013030344-A1 | PROCESS FOR THE ALKOXYCARBONYLATION OF FUNCTIONALIZED ALKENES | DSM IP ASSETS B.V. (NL) | 2013-03-07 | — | — | WO | claimed |
| WO-2013013990-A1 | PROCESS FOR THE ISOMERISATION OF SUBSTITUTED ALKENES | DSM IP ASSETS B.V. (NL) | 2013-01-31 | — | — | WO | claimed |
| EP-1527038-B1 | PROCESS FOR THE CARBONYLATION OF ETHYLENICALLY UNSATURATED COMPOUDS | LUCITE INT UK LTD (GB) | 2010-03-17 | — | — | EP | claimed |
| EP-2750799-B1 | PROCESS FOR THE ALKOXYCARBONYLATION OF FUNCTIONALIZED ALKENES | DSM IP ASSETS BV (NL) | 2016-01-06 | — | — | EP | disclosed |
| US-9056829-B2 | Process for the alkoxycarbonylation of functionalized alkenes | DSM IP ASSETS B.V. (NL) | 2015-06-16 | — | — | US | disclosed |
| US-8853434-B2 | Process for the isomerisation of substituted alkenes | DSM IP ASSETS B.V. (NL) | 2014-10-07 | — | — | US | disclosed |
| US-20140206893-A1 | PROCESS FOR THE ALKOXYCARBONYLATION OF FUNCTIONALIZED ALKENES | DSM IP ASSETS B.V. (NL) | 2014-07-24 | — | — | US | disclosed |
| US-20140206898-A1 | PROCESS FOR THE ISOMERISATION OF SUBSTITUTED ALKENES | DSM IP ASSETS B.V. (NL) | 2014-07-24 | — | — | US | disclosed |
| US-7485739-B2 | Catalyst system | LUCITE INTERNATIONAL UK LTD. (GB) | 2009-02-03 | — | — | US | disclosed |
| US-20060252935-A1 | Catalyst system | LUCITE INTERNATIONAL UK LIMITED (GB) | 2006-11-09 | — | — | US | disclosed |
| US-6376715-B1 | FROM AN ORGANOMETALLIC COMPOUND | INEOS ACRYLICS U.K. LIMITED (GB) | 2002-04-23 | — | — | US | disclosed |
| US-6348621-B1 | REACTING ETHYLENE WITH CARBON MONOXIDE IN PRESENCE OF WATER OR ORGANIC HYDROXYL GROUPS AND CATALYST SYSTEM OBTAINED BY COMBINING METAL OF GROUP VIII OR COMPOUND THEREOF AND SPECIFIED BIDENTATE PHOSPHINE COMPOUND | IMPERIAL CHEMICAL INDUSTRIES PLC (GB) | 2002-02-19 | — | — | US | disclosed |
| US-6335471-B1 | REACTING DIHALOALKYL ARYL COMPOUND WITH METAL TO FORM GRIGNARD REAGENT, REACTING WITH DISUBSTITUTED PHOSPHINE HALIDE TO FORM DIPHOSPHINE COMPOUND USEFUL AS LIGAND FOR CARBONYLATION CATALYSTS | INEOS ACRYLICS UK LIMITED (GB) | 2002-01-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060252935-A1 | Catalyst system | ELOB, SOD1, ESR1 | ESR1 3/4885SLC6A2 4745/4885HTR2A 2694/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.